Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
lat8881 (3 trials)
Migraine Disorders (Phase 2)
Neuralgia (Phase 2)
Neuralgia, Postherpetic (Phase 2)
Peripheral Nervous System Diseases (Phase 2)
Trials (3 total)
Trial APIs (1 total)